A facile and convergent approach for the total synthesis of 14-membered resorcylic acid lactone paecilomycin F is described. The synthesis emanates from the readily available inexpensive (+)-diethyl L-tartrate. Mitsunobu etherification, Stille coupling and ring-closing metathesis are key steps in the synthesis.
Introduction
The impressive biological properties i.e., antifungal, 1 antibiotic, 2 inhibition of ATPase activity of HSP90, 3 exhibited by the first resorcylic acid lactone (RAL) radicicol (Figure 1 ), 4 a 14-membered benzannulated macrolide, has attracted significant attention to the related RALs 5 (both synthetic and natural RALs) which have emerged over the last two decades. The resorcylic acid lactones with unique structural architecture are also found to exhibit potent biological activities ranging from antimalarial, 6 antiviral, antiparasitic, 7 antifungal, 8 cytotoxic, 9 estrogenic 10 to nematocidal 11 activities. Over the years, these molecules have emerged as common targets for total synthesis and have led medicinal chemists to design analog programmes leading to a number of clinical trials. [12] [13] [14] [15] Chen et al. have recently isolated six new resorcylic acid lactones, namely paecilomycin A-F [16] [17] [18] ( Figure 1 ) along with other known RALs from the mycelial solid culture of Paecilomyces fungus SC0924. Interestingly, when these compounds were subjected to screening for plasmodicidal activity, paecilomycin F was found to display antiplasmodial activity against Plasmodium falciparum line 3D7 with an IC 50 value of 20.0 nM and moderate activity against P. falciparum line Dd2. Eventhough, the structures of these compounds were determined we present a facile and convergent strategy for the total synthesis of paecilomycin F. 
Results and Discussion
Our retrosynthesis is based on a convergent approach and involved two key intermediates, an aliphatic chiral chain 8 comprising a double bond and a secondary alcohol, and an aromatic acid (9) . These two compounds can be coupled in an esterification followed by a ring closing metathesis to provide the precursor skeleton for the target molecule. The aromatic acid 9 can be synthesized from 2,4,6-trihydroxybenzoic acid in five known steps, and the aliphatic side chain 8 can be synthesized from the alcohol 11 by a four step sequence, i.e. oxidation, allylation, MOM protection of the resulting allyl alcohol, and deprotection of the TBDPS moiety (Scheme 1). The alcohol 11 can be synthesized from alkyne 12 in a one-pot reaction through hydrogenation, which in turn can be synthesized by a coupling reaction of terminal alkyne 13 with triflate 14.
The triflate is easily accessible from the commercially available (+)-diethyl L-tartrate (L(+)-DET).
Scheme 1. Retrosynthesis of paecilomycin F.
The synthesis began with isopropylidene protection 29 of the readily available (+)-diethyl Ltartrate to get the corresponding acetonide product 15 followed by the diester reduction with lithium aluminium hydride to deliver 1,4-diol 16. The diol 16 was sequentially protected as the corresponding benzyl ether 17 by treatment with benzyl bromide and NaH and activated as the triflate 14 by triflic anhydride in presence of 2,6-lutidine to set up the stage for coupling with the terminal acetylene 13. The alkyne 13 (obtained from the commercially available (S)-but-3-yne-2-ol after protection with TBDPSCl) was metalated with n-BuLi in presence of hexamethylphosphoramide (HMPA) and treated with triflate 14 to furnish the di-substituted alkyne 12. 30 One pot benzyl deprotection and alkyne reduction was achieved smoothly with Pd/C under hydrogen atmosphere to provide the primary alcohol 11 in good yield (Scheme 2). The alcohol 11 was oxidized under Swern conditions 31 to yield the aldehyde and then subjected to allylation with allyl bromide in presence of Zinc 32 and NH 4 Cl and further treated with MOM-Cl to furnish the corresponding MOM ethers. The product obtained after allylation was a mixture of diastereomers, which were inseparable and were directly treated with MOM-Cl to get the corresponding MOM ethers (9:1) which were easily separable by column chromatography. Based on the earlier experience for the allylation reaction, 19, 21 we proceeded further with the major diastereomer 18. Thus, treatment of the major diastereomer 18 with TBAF resulted in the formation of 8, the key side chain fragment with the required stereochemistry.
The other key fragment aromatic acid 9 was synthesized starting from 2,4,6-trihydroxybenzoic acid 10 (THBA) following known protocols as shown in Scheme 3. Thus, THBA 10 was treated with trifluoroacetic acid (TFA) and trifluoroacetic anhydride (TFAA) following Danishefsky's protocol 33 Scheme 2. Synthesis of aliphatic chiral key intermediate 8.
With the two key intermediates 8 and 9 in hand, the stage was set to proceed further for coupling to get the macrocyclic core skeleton. This was performed under Steglich esterification conditions 36 to furnish the ester 23 in 67% yield. Although, our initial attempts at ring-closing metathesis of 23 with Grubbs first generation catalyst did not succeed and ended up with the recovery of starting material, the reaction was successful with Grubbs second generation catalyst 37 in CH 2 Cl 2 at room temperature to provide the desired core structure 24 exclusively in 85% yield (Scheme 4). The geometry of the product was characterized based on the coupling constant value of 14.9 Hz for the olefinic protons. The compound 24 when exposed to 2N HCl for 15 h underwent complete deprotection of MOM and acetonide functionalities furnishing the target molecule paecilomycin F. The spectroscopic data of the synthesized product was in full agreement with the reported data 16, 18 of the natural product (See 
Conclusions
We have achieved a total synthesis of paecilomycin F from the readily available (+)-diethyl Ltartrate. Ring closing metathesis and standard DCC, DMAP coupling (Steglich esterification) have been once again pivotal for constructing the macrocycle core. The synthesis involved 12 steps with an overall yield of 14 %. Synthesis of other paecilomycins are currently being investigated in our laboratory.
Experimental Section
General. Column chromatography was performed using silica gel 60-120 mesh. All the solvents were dried and distilled prior to use. IR spectra were recorded on a Perkin-Elmer Infrared spectrophotometer as neat or in CHCl 3 as a thin film or as KBr wrafers. 1 (13) . TBDPSCl (4.4 mL, 17.14 mmol) was slowly added to a solution of (S)-but-3-yn-2-ol (1.0 g, 14.28 mmol) and imidazole (3.75 mL, 35.7 mmol) in CH 2 Cl 2 (20 mL) at 0 o C and the resulting mixture was stirred for 15 h at room temperature. After 15 h, CH 2 Cl 2 (10 mL) and H 2 O (20 mL) were added. The layers were separated and the aqueous phase extracted with CH 2 Cl 2 (3 × 20 mL). The combined organic phase was washed with brine (20 mL), dried over Na 2 SO 4 , concentrated under reduced pressure, and purified by silica gel column chromatography (hexane/EtOAc 98:2) to afford 13 (3.87 g, 94%) as a colorless oil. R f 0. 8 (12) . To a solution of compound 17 (700 mg, 2.78 mmol) in CH 2 Cl 2 (20 mL) was added a solution of trifluoromethanesulfonic anhydride (0.5 mL, 3.05 mmol) at -78 °C over 5 min, and the resulting solution was stirred for 30 min. To the reaction mixture was added saturated NH 4 Cl (5 mL) with CH 2 Cl 2 (40 mL). The organic layer was washed with brine (10 mL), dried over Na 2 SO 4 , and concentrated under reduced pressure to give the crude product (0.9 g) as pale yellow oil. The product was passed through short pad of silica gel column chromatography (hexane/EtOAc 9:1) to afford crude 14 (1.01 g, 95%) as a colorless oil. R f 0.8 (hexane/EtOAc 7:3). A solution of n-BuLi (1.46 mL of a 1.6 M solution in hexane, 2.34 mmol) was added dropwise to a solution of compound 13 (0.818 g, 2.6 mmol) in THF (15 mL) over 5 min at 0 o C. Once addition was complete, the reaction mixture was warmed to rt for 1 h, then recooled to -78 o C. HMPA (1.6 mL, 9.36 mmol) was added via syringe, and the resultant solution was stirred for 10 min. A solution of compound 14 (0.6 g, 1.56 mmol) in THF (10 mL) was added dropwise over 5 min. The mixture was stirred at rt for 6 h, then quenched with saturated aqueous NH 4 Cl (10 mL). The layers were separated, and aqueous phase was extracted with EtOAc (3 × 20 mL). The combined organic phase was washed with brine (20 mL), dried over anhydrous Na 2 SO 4 , filtered and concentrated under reduced pressure. The crude product was purified by silica gel column chromatography (hexane/ (11) . The compound 12 (0.55 g, 1.2 mmol) was dissolved in THF (20 mL) and commercial Pd/C (55 mg, 10% w/w) was added. The resulting suspension was stirred under an atmosphere of H 2 for 15 h until complete conversion of the substrate occurred. The suspension was filtered through celite which was rinsed with EtOAc (150 mL). The combined filtrates were washed with brine (30 mL), dried over anhydrous Na 2 SO 4 , filtered and concentrated under reduced pressure. The crude product was purified by silica gel column chromatography (hexane/EtOAc 8:2) to afford 11 as a colorless liquid (414 mg, 90%). (18) . To a solution of oxalyl chloride (0.11 mL, 1.14 mmol) in CH 2 Cl 2 (5 mL) was added a solution of DMSO (0.19 mL, 2.63 mmol) in CH 2 Cl 2 (2 mL) at -78 o C, and the resulting solution was stirred for 10 min at the same temperature. A solution of the alcohol 11 (0.3 g, 0.657 mmol) in CH 2 Cl 2 (3 mL) was added dropwise over 5 min. After the solution had stirred for an additional 30 min, Et 3 N (0.548 mL, 3.942 mmol) was added and the reaction mixture was allowed to warm to room temperature. The reaction mixture was poured into H 2 O, extracted with CH 2 Cl 2 (2 × 10 mL). The organic layers were washed with brine (10 mL), dried over Na 2 SO 4 , and concentrated under reduced pressure to give the crude aldehyde (2.3 g) as pale yellow oil. To a pre-cooled (10 °C) and well-stirred mixture of crude aldehyde (0.3 g, 0.657 mmol) in THF (5 mL), zinc dust (0.172 g, 2.64 mmol) and allyl bromide (0.112 mL, 1.32 mmol) in THF (5 mL) was added a saturated aqueous solution of NH 4 Cl (0.1 mL) in portions over a period of 10 min. The reaction started vigorously soon after the addition of the first portion of the salt solution. The mixture was stirred for 5 h till the complete disappearance of the aldehyde (TLC). The reaction was quenched with MOM-Cl (0.084 mL, 1.058 mmol) at 0 o C and the resulting mixture was stirred for 6 h at room temperature. The mixture was filtered and washed with EtOAc (50 mL 
S)-(But-3-yn-2-yloxy)(t-butyl)diphenylsilane
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Paecilomycin F (7)
. A solution of compound 24 (40 mg, 0.067 mmol) in THF (5 mL) was treated with 2N HCl (5 mL) and allowed to stir for 15 h, then EtOAc (5 mL) and H 2 O (5 mL) were added. The layers were separated and the aqueous phase was extracted with EtOAc (2x 5 mL). The combined organic portion was washed with saturated sodium bicarbonate solution (10 mL) followed by brine solution (10 mL), dried over Na 2 SO 4 , and then concentrated under reduced pressure, the residue was purified by silica gel column chromatography (hexane/EtOAc 4:6) to give paecilomycin F 7 as white solid (21 mg, 87% 
